TASC II section F on revascularization: Commentary from an interventionist's point of view

Journal of Endovascular Therapy

Volumn 14, Issue 5, 2007, Pages 734-742

  Schillinger, Martin ^a   Diehm, Nicolas ^b   Baumgartner, Iris ^b   Minar, Eric ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; RAPAMYCIN;

ADJUVANT THERAPY; BYPASS SURGERY; CLINICAL PRACTICE; COMORBIDITY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; HUMAN; INTERMITTENT CLAUDICATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEG REVASCULARIZATION; LIMB ISCHEMIA; NOTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVASCULARIZATION; STENT; THROMBOSIS; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; BLOOD PRESSURE; EVIDENCE-BASED MEDICINE; EXTREMITIES; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 35348953690     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2007)14[734:TISFOR]2.0.CO;2     Document Type: Note

References (18)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Section F: Revascularization. Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S54-S64.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
3. Tetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998;351:1153-1159.
4. Klein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006;238:734-744.
5. Adam DJ, Beard JD, Cleveland T, et al. Bypass surgery versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.
6. Ponec D, Jaff MR, Swischuk J, et al. The nitinol SMART stent vs. Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004;15:911-918.
7. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87-96.
8. Cejna M, Turnher S, Illiasch H, et al. PTA versus Palmaz stent in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
9. Vroegineweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
10. Grimm J, Müller-Hülsbeck S, Jahnke T, et al. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-942.
11. Zdanowski Z, Albrechtsson U, Lundin A, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999;18:251-255.
12. Becquemin JP, Favre JP, Marzelle J, et al. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomised study. J Vasc Surg. 2003;37:487-494.
13. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results. Circulation. 2002;106:1505-1509.
14. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
15. Krankenberg H for the FAST Investigators. Femoral artery stenting trial-12-month final analysis. Presented at Transcatheter Cardiovascular Therapies; October 22-27, 2006; Washington, DC, USA.
16. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710.
17. Schillinger M, Mlekusch W, Haumer M, et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003;10:288-297.
18. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83(2 Suppl):I70-I80.